RxDoctor Payments Data

Alyssa Doyle

Nurse Practitioner · Flint, MINPI 1215528310

Payments from drug & device makers

What this record shows

23 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 36.8% of the total. 2025 is the largest year on record at $7,849, more than ten times the $30 reported in 2021. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,164in general payments, 2019–2025

Across 152 payments — averaging $73.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$4K
  • Boston Scientific$4K
  • Globus Medical$1K
  • Nevro Corp.$531
  • AbbVie$270
  • Amgen$269
  • plus $950 from 17 others

What the payments were for

  • Travel & lodging$4,78143%
  • Food & beverage$6,38357%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,164 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$37,995
Medicare patients
120
Services billed
628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl27$27,403
Buprenorphine84$22,226
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,415$21,750
Acetaminophen-CodeineAcetaminophen With Codeine793$21,300
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen852$14,233
Gabapentin998$12,709
Pregabalin685$11,632
Tizanidine Hcl324$5,163
Diclofenac Sodium251$4,269
Cyclobenzaprine Hcl640$3,240
Duloxetine Hcl227$3,156
Methocarbamol148$1,947
Ibuprofen193$1,574
Lidocaine13$1,297
Tramadol Hcl253$1,270

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →